Exact Mass: 553.3475312

LysoPE(0:0/24:6(6Z,9Z,12Z,15Z,18Z,21Z))

C29H48NO7P (553.3168)

LysoPE(0:0/24:6(6Z,9Z,12Z,15Z,18Z,21Z)) or LPE(0:0/24:6(6Z,9Z,12Z,15Z,18Z,21Z)) is a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/24:6(6Z,9Z,12Z,15Z,18Z,21Z)) or LPE(0:0/24:6(6Z,9Z,12Z,15Z,18Z,21Z)) is a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.

LysoPE(24:6(6Z,9Z,12Z,15Z,18Z,21Z)/0:0)

C29H48NO7P (553.3168)

LysoPE(24:6(6Z,9Z,12Z,15Z,18Z,21Z)/0:0) or LPE(24:6(6Z,9Z,12Z,15Z,18Z,21Z)/0:0) is a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(24:6(6Z,9Z,12Z,15Z,18Z,21Z)/0:0) or LPE(24:6(6Z,9Z,12Z,15Z,18Z,21Z)/0:0) is a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.

Gly-Pro-Arg-Pro-Lys

C24H43N9O6 (553.3336)

Bowdichine

C31H43N3O6 (553.3152)

15-O-veratroyl-17-O-acetyldictysine

C32H43NO7 (553.3039)

izenamicin B2

C30H51NO8 (553.3614)

(E)-3-[3-(3-methoxy-4-hydroxyphenyl)prop-1-enyl]-2,4,6-triphenethylpyridine

C39H39NO2 (553.2981)

??-Lactorphin

C30H43N5O5 (553.3264)

Juvenimicin A2

C30H51NO8 (553.3614)

Arg His Asn Lys

C22H39N11O6 (553.3085)

Leu Leu Leu Pro Gly

C28H51N5O6 (553.3839)

His Asn Lys Arg

C22H39N11O6 (553.3085)

dimethyl (2E,6E,11Z)-19-(2-amino-2-oxoethyl)-9,13-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxohenicosa-2,6,11-trienedioate

C29H47NO9 (553.3251)

dimethyl (2E,6E,11Z)-19-(2-amino-2-oxoethyl)-9,13-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxohenicosa-2,6,11-trienedioate [IIN-based on: CCMSLIB00000846986]

C29H47NO9 (553.3251)

dimethyl (2E,6E,11Z)-19-(2-amino-2-oxoethyl)-9,13-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxohenicosa-2,6,11-trienedioate [IIN-based on: CCMSLIB00000846980]

C29H47NO9 (553.3251)

dimethyl (2E,6E,11Z)-19-(2-amino-2-oxoethyl)-9,13-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxohenicosa-2,6,11-trienedioate [IIN-based: Match]

C29H47NO9 (553.3251)

Phe Phe Ile Lys

C30H43N5O5 (553.3264)

Phe Phe Lys Ile

C30H43N5O5 (553.3264)

Phe Phe Lys Leu

C30H43N5O5 (553.3264)

Phe Phe Leu Lys

C30H43N5O5 (553.3264)

Phe Ile Phe Lys

C30H43N5O5 (553.3264)

Phe Ile Lys Phe

C30H43N5O5 (553.3264)

Phe Lys Phe Ile

C30H43N5O5 (553.3264)

Phe Lys Phe Leu

C30H43N5O5 (553.3264)

Phe Lys Ile Phe

C30H43N5O5 (553.3264)

Phe Lys Leu Phe

C30H43N5O5 (553.3264)

Phe Leu Phe Lys

C30H43N5O5 (553.3264)

Phe Leu Lys Phe

C30H43N5O5 (553.3264)

His Ile Val Trp

C28H39N7O5 (553.3013)

His Ile Trp Val

C28H39N7O5 (553.3013)

His Lys Asn Arg

C22H39N11O6 (553.3085)

His Lys Arg Asn

C22H39N11O6 (553.3085)

His Leu Val Trp

C28H39N7O5 (553.3013)

His Leu Trp Val

C28H39N7O5 (553.3013)

His Asn Arg Lys

C22H39N11O6 (553.3085)

His Arg Lys Asn

C22H39N11O6 (553.3085)

His Arg Asn Lys

C22H39N11O6 (553.3085)

His Val Ile Trp

C28H39N7O5 (553.3013)

His Val Leu Trp

C28H39N7O5 (553.3013)

His Val Trp Ile

C28H39N7O5 (553.3013)

His Val Trp Leu

C28H39N7O5 (553.3013)

His Trp Ile Val

C28H39N7O5 (553.3013)

His Trp Leu Val

C28H39N7O5 (553.3013)

His Trp Val Ile

C28H39N7O5 (553.3013)

His Trp Val Leu

C28H39N7O5 (553.3013)

Ile Phe Phe Lys

C30H43N5O5 (553.3264)

Ile Phe Lys Phe

C30H43N5O5 (553.3264)

Ile His Val Trp

C28H39N7O5 (553.3013)

Ile His Trp Val

C28H39N7O5 (553.3013)

Ile Lys Phe Phe

C30H43N5O5 (553.3264)

Ile Val His Trp

C28H39N7O5 (553.3013)

Ile Val Trp His

C28H39N7O5 (553.3013)

Ile Trp His Val

C28H39N7O5 (553.3013)

Ile Trp Val His

C28H39N7O5 (553.3013)

Lys Phe Phe Ile

C30H43N5O5 (553.3264)

Lys Phe Phe Leu

C30H43N5O5 (553.3264)

Lys Phe Ile Phe

C30H43N5O5 (553.3264)

Lys Phe Leu Phe

C30H43N5O5 (553.3264)

Lys His Asn Arg

C22H39N11O6 (553.3085)

Lys His Arg Asn

C22H39N11O6 (553.3085)

Lys Ile Phe Phe

C30H43N5O5 (553.3264)

Lys Leu Phe Phe

C30H43N5O5 (553.3264)

Lys Asn His Arg

C22H39N11O6 (553.3085)

Lys Asn Arg His

C22H39N11O6 (553.3085)

Lys Arg His Asn

C22H39N11O6 (553.3085)

Lys Arg Asn His

C22H39N11O6 (553.3085)

Leu Phe Phe Lys

C30H43N5O5 (553.3264)

Leu Phe Lys Phe

C30H43N5O5 (553.3264)

Leu His Val Trp

C28H39N7O5 (553.3013)

Leu His Trp Val

C28H39N7O5 (553.3013)

Leu Lys Phe Phe

C30H43N5O5 (553.3264)

Leu Val His Trp

C28H39N7O5 (553.3013)

Leu Val Trp His

C28H39N7O5 (553.3013)

Leu Trp His Val

C28H39N7O5 (553.3013)

Leu Trp Val His

C28H39N7O5 (553.3013)

Asn His Lys Arg

C22H39N11O6 (553.3085)

Asn His Arg Lys

C22H39N11O6 (553.3085)

Asn Lys His Arg

C22H39N11O6 (553.3085)

Asn Lys Arg His

C22H39N11O6 (553.3085)

Asn Arg His Lys

C22H39N11O6 (553.3085)

Asn Arg Lys His

C22H39N11O6 (553.3085)

Arg His Lys Asn

C22H39N11O6 (553.3085)

Arg Lys His Asn

C22H39N11O6 (553.3085)

Arg Lys Asn His

C22H39N11O6 (553.3085)

Arg Asn His Lys

C22H39N11O6 (553.3085)

Arg Asn Lys His

C22H39N11O6 (553.3085)

Val His Ile Trp

C28H39N7O5 (553.3013)

Val His Leu Trp

C28H39N7O5 (553.3013)

Val His Trp Ile

C28H39N7O5 (553.3013)

Val His Trp Leu

C28H39N7O5 (553.3013)

Val Ile His Trp

C28H39N7O5 (553.3013)

Val Ile Trp His

C28H39N7O5 (553.3013)

Val Leu His Trp

C28H39N7O5 (553.3013)

Val Leu Trp His

C28H39N7O5 (553.3013)

Val Trp His Ile

C28H39N7O5 (553.3013)

Val Trp His Leu

C28H39N7O5 (553.3013)

Val Trp Ile His

C28H39N7O5 (553.3013)

Val Trp Leu His

C28H39N7O5 (553.3013)

Trp His Ile Val

C28H39N7O5 (553.3013)

Trp His Leu Val

C28H39N7O5 (553.3013)

Trp His Val Ile

C28H39N7O5 (553.3013)

Trp His Val Leu

C28H39N7O5 (553.3013)

Trp Ile His Val

C28H39N7O5 (553.3013)

Trp Ile Val His

C28H39N7O5 (553.3013)

Trp Leu His Val

C28H39N7O5 (553.3013)

Trp Leu Val His

C28H39N7O5 (553.3013)

Trp Val His Ile

C28H39N7O5 (553.3013)

Trp Val His Leu

C28H39N7O5 (553.3013)

Trp Val Ile His

C28H39N7O5 (553.3013)

Trp Val Leu His

C28H39N7O5 (553.3013)

LysoPE(0:0/24:6(6Z,9Z,12Z,15Z,18Z,21Z))

C29H48NO7P (553.3168)

LysoPE(24:6(6Z,9Z,12Z,15Z,18Z,21Z)/0:0)

C29H48NO7P (553.3168)

PS(20:0/0:0)

C26H52NO9P (553.338)

LPE 24:6

C29H48NO7P (553.3168)

LPS 20:0

C26H52NO9P (553.338)

PS-PE

C25H48NO10P (553.3016)

(S)-methyl 2-((S)-2-tert.butoxycarbonyIamino-4-phenylbutanamido-4-methylpentanamido)-3-phenylpropanoate

C31H43N3O6 (553.3152)

Dusquetide

C25H47N9O5 (553.37)

Dusquetide (SGX942) is a first-in-class innate defense regulator (IDR). Dusquetide modulates the innate immune response to both PAMPs and DAMPs by binding to p62. Dusquetide shows activity in both reducing inflammation and increasing clearance of bacterial infection[1]. DAMPs: damage-associated molecular patterns; PAMPs: pathogen-associated molecular patterns

L-arginyl-L-isoleucyl-L-valyl-L-prolyl-L-alaninamide

C25H47N9O5 (553.37)

C308 - Immunotherapeutic Agent > C574 - Immunosuppressant

(3alpha,5beta,7alpha)-3-(beta-D-glucopyranosyloxy)-7-hydroxycholan-24-oate

C30H49O9- (553.3376)

N-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide

C32H47N3O5 (553.3516)

N-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide

C32H47N3O5 (553.3516)

N-[[(3R,9R,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide

C32H47N3O5 (553.3516)

1-Palmitoyl-2-(5-hydroxyvaleroyl)-sn-glycero-3-phosphoethanolamine

C26H52NO9P (553.338)

N-[[(3S,9R,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide

C32H47N3O5 (553.3516)

N-[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide

C32H47N3O5 (553.3516)

N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide

C30H43N5O5 (553.3264)

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide

C30H43N5O5 (553.3264)

N-[[(3R,9R,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide

C32H47N3O5 (553.3516)

N-[[(3S,9S,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide

C32H47N3O5 (553.3516)

N-[[(3S,9R,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide

C32H47N3O5 (553.3516)

N-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide

C32H47N3O5 (553.3516)

N-[[(3R,9R,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide

C32H47N3O5 (553.3516)

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide

C30H43N5O5 (553.3264)

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide

C30H43N5O5 (553.3264)

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide

C30H43N5O5 (553.3264)

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide

C30H43N5O5 (553.3264)

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide

C30H43N5O5 (553.3264)

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide

C30H43N5O5 (553.3264)

N-[[(3S,9R,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide

C32H47N3O5 (553.3516)

N-[[(3S,9R,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide

C32H47N3O5 (553.3516)

N-[(3S,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide

C32H47N3O5 (553.3516)

N-[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide

C32H47N3O5 (553.3516)

N-[[(3S,9S,10S)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide

C32H47N3O5 (553.3516)

N-[[(3R,9R,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide

C32H47N3O5 (553.3516)

N-[[(3S,9S,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide

C32H47N3O5 (553.3516)

N-[[(3S,9S,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide

C32H47N3O5 (553.3516)

N-[[(3R,9S,10R)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide

C32H47N3O5 (553.3516)

N-[[(3R,9S,10S)-16-(dimethylamino)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide

C32H47N3O5 (553.3516)

N-[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide

C32H47N3O5 (553.3516)

N-[[(3R,9S,10R)-16-(dimethylamino)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methyl-2-phenylacetamide

C32H47N3O5 (553.3516)

N-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide

C32H47N3O5 (553.3516)

4-[9-(dimethylamino)-2,2,4,11,11-pentamethylnaphtho[2,3-g]quinolin-1-ium-1-yl]-N-[2-(2,5-dioxopyrrol-1-yl)ethyl]butanamide

C34H41N4O3+ (553.3178)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-(5-hydroxypentanoyloxy)propyl] hexadecanoate

C26H52NO9P (553.338)

HexCer 8:1;2O/16:3

C30H51NO8 (553.3614)

HexCer 8:0;2O/16:4

C30H51NO8 (553.3614)

NAGly 16:4/16:3

C34H51NO5 (553.3767)

[3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H52NO6P (553.3532)

2-Amino-3-[hydroxy-(2-hydroxy-3-icosanoyloxypropoxy)phosphoryl]oxypropanoic acid

C26H52NO9P (553.338)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoate

C29H48NO7P (553.3168)

Lnaps 16:0/N-3:0

C25H48NO10P (553.3016)

Lnaps 3:0/N-16:0

C25H48NO10P (553.3016)

Lnaps 2:0/N-17:0

C25H48NO10P (553.3016)

Lnaps 9:0/N-10:0

C25H48NO10P (553.3016)

Lnaps 7:0/N-12:0

C25H48NO10P (553.3016)

Lnaps 5:0/N-14:0

C25H48NO10P (553.3016)

Lnaps 11:0/N-8:0

C25H48NO10P (553.3016)

Lnaps 8:0/N-11:0

C25H48NO10P (553.3016)

Lnaps 13:0/N-6:0

C25H48NO10P (553.3016)

Lnaps 10:0/N-9:0

C25H48NO10P (553.3016)

Lnaps 4:0/N-15:0

C25H48NO10P (553.3016)

Lnaps 17:0/N-2:0

C25H48NO10P (553.3016)

Lnaps 14:0/N-5:0

C25H48NO10P (553.3016)

Lnaps 6:0/N-13:0

C25H48NO10P (553.3016)

Lnaps 12:0/N-7:0

C25H48NO10P (553.3016)

Lnaps 15:0/N-4:0

C25H48NO10P (553.3016)

(4E,8E,12E)-3-hydroxy-2-[[(4Z,7Z)-2-hydroxyhexadeca-4,7-dienoyl]amino]tetradeca-4,8,12-triene-1-sulfonic acid

C30H51NO6S (553.3437)

(4E,8E,12E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxytetradeca-4,8,12-triene-1-sulfonic acid

C31H55NO5S (553.3801)

(4E,8E,12E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]octadeca-4,8,12-triene-1-sulfonic acid

C31H55NO5S (553.3801)

2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxypentadecane-1-sulfonic acid

C31H55NO5S (553.3801)

(4E,8E,12E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxypentadeca-4,8,12-triene-1-sulfonic acid

C31H55NO5S (553.3801)

3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]tridecane-1-sulfonic acid

C31H55NO5S (553.3801)

(4E,8E,12E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]heptadeca-4,8,12-triene-1-sulfonic acid

C31H55NO5S (553.3801)

(4E,8E)-2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxytetradeca-4,8-diene-1-sulfonic acid

C31H55NO5S (553.3801)

(E)-3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]tridec-4-ene-1-sulfonic acid

C31H55NO5S (553.3801)

(E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxypentadec-4-ene-1-sulfonic acid

C31H55NO5S (553.3801)

(4E,8E,12E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]hexadeca-4,8,12-triene-1-sulfonic acid

C31H55NO5S (553.3801)

(4E,8E)-3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]dodeca-4,8-diene-1-sulfonic acid

C31H55NO5S (553.3801)

(4E,8E)-3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]trideca-4,8-diene-1-sulfonic acid

C31H55NO5S (553.3801)

3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]undecane-1-sulfonic acid

C31H55NO5S (553.3801)

(E)-3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]undec-4-ene-1-sulfonic acid

C31H55NO5S (553.3801)

(4E,8E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxypentadeca-4,8-diene-1-sulfonic acid

C31H55NO5S (553.3801)

2-Amino-3-[(2-decanoyloxy-3-decoxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

C26H52NO9P (553.338)

dimethyl (2E,6E,11Z)-19-(2-amino-2-oxoethyl)-9,13-dihydroxy-8-methoxy-10,12,14-trimethyl-15-oxohenicosa-2,6,11-trienedioate

C29H47NO9 (553.3251)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]propan-2-yl] acetate

C29H48NO7P (553.3168)

2-Amino-3-[(2-hexadecanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

C25H48NO10P (553.3016)

2-Amino-3-[hydroxy-(3-octanoyloxy-2-undecanoyloxypropoxy)phosphoryl]oxypropanoic acid

C25H48NO10P (553.3016)

2-Amino-3-[(2-decanoyloxy-3-nonanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

C25H48NO10P (553.3016)

2-Amino-3-[(3-butanoyloxy-2-pentadecanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

C25H48NO10P (553.3016)

2-Amino-3-[hydroxy-(3-pentanoyloxy-2-tetradecanoyloxypropoxy)phosphoryl]oxypropanoic acid

C25H48NO10P (553.3016)

2-Amino-3-[(3-hexanoyloxy-2-tridecanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

C25H48NO10P (553.3016)

2-Amino-3-[(2-dodecanoyloxy-3-heptanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

C25H48NO10P (553.3016)

3-[(3-Acetyloxy-2-heptadecanoyloxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid

C25H48NO10P (553.3016)

1-eicosanoyl-glycero-3-phosphoserine

C26H52NO9P (553.338)

1-palmitoyl-2-succinyl-sn-glycero-phosphoethanolamine

C25H48NO10P (553.3016)

LdMePE(22:6)

C29H48NO7P (553.3168)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

DGCC 20:3

C30H51NO8 (553.3614)

DGTS 19:4;O2

C29H47NO9 (553.3251)

DGTS 20:3;O

C30H51NO8 (553.3614)

LPC O-22:6

C30H52NO6P (553.3532)

LPC P-22:5

C30H52NO6P (553.3532)

LPC P-22:5 or LPC O-22:6

C30H52NO6P (553.3532)

LPC 18:1;O2

C26H52NO9P (553.338)

LNAPE 21:0;O

C26H52NO9P (553.338)

PE O-16:0/5:1;O2

C26H52NO9P (553.338)

PE O-21:1;O2

C26H52NO9P (553.338)

PE 16:0/4:1;O2

C25H48NO10P (553.3016)

LPS 20:0/0:0

C26H52NO9P (553.338)

PS O-16:0/4:0

C26H52NO9P (553.338)

PS O-18:0/2:0

C26H52NO9P (553.338)

PS O-20:0

C26H52NO9P (553.338)

PS O-20:0/0:0

C26H52NO9P (553.338)

PS 15:0/4:0

C25H48NO10P (553.3016)

PS 17:0/2:0

C25H48NO10P (553.3016)

PS 19:0

C25H48NO10P (553.3016)

ST 27:2;O7;Gly

C29H47NO9 (553.3251)

ST 28:1;O6;Gly

C30H51NO8 (553.3614)

ST 21:1;O4;HexNAc

C29H47NO9 (553.3251)

ST 22:0;O3;HexNAc

C30H51NO8 (553.3614)

ST 24:6;O2;HexNAc

C32H43NO7 (553.3039)

ST 25:5;O;HexNAc

C33H47NO6 (553.3403)

ST 27:3;O4;Tau

C29H47NO7S (553.3073)

ST 28:2;O3;Tau

C30H51NO6S (553.3437)

ST 29:1;O2;Tau

C31H55NO5S (553.3801)

(1r,7s,8r,10r,13s,14r,15s,18s,23s,24r,25s,26r)-7,11,23-trihydroxy-4,15,16,20-tetramethyl-13-(2-methylpropyl)-2,27-dioxa-12-azahexacyclo[22.2.1.0⁵,²⁶.0⁸,²⁵.0¹⁰,¹⁴.0¹⁰,¹⁸]heptacosa-4,11,16,19-tetraene-6,9-dione

C32H43NO7 (553.3039)

15-veratroyl-17-acetyldictizine

C32H43NO7 (553.3039)

{"Ingredient_id": "HBIN001728","Ingredient_name": "15-veratroyl-17-acetyldictizine","Alias": "NA","Ingredient_formula": "C32H43NO7","Ingredient_Smile": "CC(=O)OCC1(C2CCC3(C1OC(=O)C4=CC(=C(C=C4)OC)OC)C5CC6C7(CCCC6(C3C2)C5N(C7)C)C)O","Ingredient_weight": "553.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "22374","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21579304","DrugBank_id": "NA"}

(1s,5r,8r,9r,10r,11s,12r,13s,15s,16r)-12-[(acetyloxy)methyl]-12-hydroxy-5,7-dimethyl-7-azahexacyclo[7.6.2.2¹⁰,¹³.0¹,⁸.0⁵,¹⁶.0¹⁰,¹⁵]nonadecan-11-yl 3,4-dimethoxybenzoate

C32H43NO7 (553.3039)

(1r)-1-[(1r,2s,13s,16s,17s,19r,20r,22s,25s,27s)-16-hydroxy-1,2,24,24-tetramethyl-18,21,23,26-tetraoxa-4-azaoctacyclo[14.13.0.0²,¹³.0³,¹¹.0⁵,¹⁰.0¹⁷,¹⁹.0¹⁷,²⁷.0²⁰,²⁵]nonacosa-3(11),5,7,9-tetraen-22-yl]-2-methylpropane-1,2-diol

C32H43NO7 (553.3039)

(1s)-1-[(1r,2s,13s,16s,17s,19r,20r,22s,25s,27s)-16-hydroxy-1,2,24,24-tetramethyl-18,21,23,26-tetraoxa-4-azaoctacyclo[14.13.0.0²,¹³.0³,¹¹.0⁵,¹⁰.0¹⁷,¹⁹.0¹⁷,²⁷.0²⁰,²⁵]nonacosa-3(11),5,7,9-tetraen-22-yl]-2-methylpropane-1,2-diol

C32H43NO7 (553.3039)

7,11,23-trihydroxy-4,15,16,20-tetramethyl-13-(2-methylpropyl)-2,27-dioxa-12-azahexacyclo[22.2.1.0⁵,²⁶.0⁸,²⁵.0¹⁰,¹⁴.0¹⁰,¹⁸]heptacosa-4,11,16,19-tetraene-6,9-dione

C32H43NO7 (553.3039)

(3s)-3-{[(1s)-1-{[(1e,3s)-1,4-dimethyl-1-(sulfanylcarbonyl)pent-1-en-3-yl](methyl)carbamoyl}-2,2-dimethylpropyl]-c-hydroxycarbonimidoyl}-2,4,4,9-tetramethyl-3h-pyrido[3,4-b]indol-2-ium

[C31H45N4O3S]+ (553.3212)

(2r,3r,12bs)-3-ethyl-2-{[(1s)-2-methyl-1h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]methyl}-11-[(2s)-1-methylpyrrolidin-2-yl]-1h,2h,3h,4h,6h,7h,7ah,12h,12ah,12bh-indolo[2,3-a]quinolizin-10-ol

C35H47N5O (553.378)

(14e)-9-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-2,8,10,12,16-pentamethyl-4,17-dioxabicyclo[14.1.0]heptadec-14-ene-5,13-dione

C30H51NO8 (553.3614)

(3s,6s,9r,12s)-5,8,11,14,17-pentahydroxy-3,12-diisopropyl-6-methyl-9-(2-methylpropyl)-19-propyl-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13,16-pentaen-2-one

C27H47N5O7 (553.3475)

(11z,13z)-6-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-16-ethyl-4-hydroxy-15-(hydroxymethyl)-5,7,9,13-tetramethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione

C30H51NO8 (553.3614)

n-{[12-(prop-2-en-1-yl)-8-[4-(3,4,5-trimethoxybenzoyloxy)butyl]-1,7-diazatetracyclo[7.3.1.0²,⁷.0⁶,¹¹]tridecan-5-ylidene]methyl}ethanimidic acid

C31H43N3O6 (553.3152)

1-{16-hydroxy-1,2,24,24-tetramethyl-18,21,23,26-tetraoxa-4-azaoctacyclo[14.13.0.0²,¹³.0³,¹¹.0⁵,¹⁰.0¹⁷,¹⁹.0¹⁷,²⁷.0²⁰,²⁵]nonacosa-3(11),5,7,9-tetraen-22-yl}-2-methylpropane-1,2-diol

C32H43NO7 (553.3039)

12-[(acetyloxy)methyl]-12-hydroxy-5,7-dimethyl-7-azahexacyclo[7.6.2.2¹⁰,¹³.0¹,⁸.0⁵,¹⁶.0¹⁰,¹⁵]nonadecan-11-yl 3,4-dimethoxybenzoate

C32H43NO7 (553.3039)